MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing a non-invasive method to detect drug and alcohol impairment using artificial intelligence and voice analytics, potentially transforming traditional testing approaches that rely on breath, saliva, or laboratory analysis. The company's platform analyzes more than 140 acoustic markers from short voice samples, trained on over 50 million data points, to estimate intoxication levels.
The global alcohol and drug testing devices market is projected to grow from $2.5 billion in 2025 to $4.2 billion by 2033, driven by rising safety requirements and stricter regulatory oversight. MindBio's initial commercial focus is on the mining industry, particularly in South America, where large workforces and high-risk environments create demand for rapid impairment screening. Other potential applications include aviation, construction, call centers, law enforcement, and mental health settings, where high-volume screening is often expensive and time-consuming.
Employers are under increasing pressure to improve safety while reducing the cost and friction of traditional testing methods, creating an opportunity for companies like MindBio to modernize a process that remains heavily dependent on breathalyzers, urine testing, and laboratory analysis. The company's AI-driven approach could offer a faster, less intrusive alternative.
MindBio Therapeutics is positioning itself in the workplace drug and alcohol detection space with its voice analytics technology, which the company has spent several years developing. For more information, visit the company's newsroom at https://ibn.fm/MBQIF.
This announcement was disseminated on behalf of MindBio Therapeutics and may include paid advertising. TechMediaWire, a specialized communications platform, distributed this content. TechMediaWire is one of 75+ brands within the Dynamic Brand Portfolio @IBN that provides access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and a full array of tailored corporate communications solutions. For more information about TechMediaWire, visit https://www.TechMediaWire.com. Please see full terms of use and disclaimers on the TechMediaWire website at https://www.TechMediaWire.com/Disclaimer.
